IPAC2021 - List of Authors (Lombardi, A.M.)

Paper	Title	Page
MOPAB413	The Next Ion Medical Machine Study at CERN: Towards a Next Generation Cancer Research and Therapy Facility with Ion Beams	1240
	M. Vretenar, V. Bencini, E. Benedetto, M.R. Khalvati, A.M. Lombardi, M. Sapinski, D. Tommasini CERN, Geneva, Switzerland E. Benedetto, M. Sapinski TERA, Novara, Italy P. Foka GSI, Darmstadt, Germany
	Cancer therapy with ions has several advantages over X-ray and proton therapy, but its diffusion remains limited primarily because of the size and cost of the accelerator. To develop technologies that might improve performance and reduce accelerator cost with respect to present facilities, CERN has recently launched the Next Ion Medical Machine Study (NIMMS), leveraging CERN expertise in accelerator fields to disseminate technologies developed for basic science. A perspective user and key partner of NIMMS is the SEEIIST (South East European International Institute for Sustainable Technologies), established to build in the region an innovative facility for combined cancer therapy and biomedical research with ion beams. For SEEIIST and other potential users, three options are being considered. Conceptual designs of a warm-magnet synchrotron at high beam intensity, of a compact superconducting synchrotron, and of a high-frequency linear accelerator have been compared in terms of cost, risk and development time. The development of curved superconducting magnets, of compact synchrotrons and ion gantries, and of linacs is being pursued within EU-funded projects or specific collaborations
DOI •	reference for this paper ※ https://doi.org/10.18429/JACoW-IPAC2021-MOPAB413
About •	paper received ※ 18 May 2021 paper accepted ※ 20 July 2021 issue date ※ 13 August 2021
Export •	reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)

Paper

Title

Page

The Next Ion Medical Machine Study at CERN: Towards a Next Generation Cancer Research and Therapy Facility with Ion Beams

1240

M. Vretenar, V. Bencini, E. Benedetto, M.R. Khalvati, A.M. Lombardi, M. Sapinski, D. Tommasini
CERN, Geneva, Switzerland
E. Benedetto, M. Sapinski
TERA, Novara, Italy
P. Foka
GSI, Darmstadt, Germany

Cancer therapy with ions has several advantages over X-ray and proton therapy, but its diffusion remains limited primarily because of the size and cost of the accelerator. To develop technologies that might improve performance and reduce accelerator cost with respect to present facilities, CERN has recently launched the Next Ion Medical Machine Study (NIMMS), leveraging CERN expertise in accelerator fields to disseminate technologies developed for basic science. A perspective user and key partner of NIMMS is the SEEIIST (South East European International Institute for Sustainable Technologies), established to build in the region an innovative facility for combined cancer therapy and biomedical research with ion beams. For SEEIIST and other potential users, three options are being considered. Conceptual designs of a warm-magnet synchrotron at high beam intensity, of a compact superconducting synchrotron, and of a high-frequency linear accelerator have been compared in terms of cost, risk and development time. The development of curved superconducting magnets, of compact synchrotrons and ion gantries, and of linacs is being pursued within EU-funded projects or specific collaborations

DOI •

reference for this paper ※ https://doi.org/10.18429/JACoW-IPAC2021-MOPAB413

About •

paper received ※ 18 May 2021 paper accepted ※ 20 July 2021 issue date ※ 13 August 2021

Export •

reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)